Clinical Trials Browser

Phase 1 × Metaplasia × Erlotinib Hydrochloride × Clear all

NCT01013831 2015-02-18

Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the Lung

Phase 1 Terminated

Metaplasia